Evaluation of Knowledge Among Adolescents With Sickle Cell Disease. (SEXODREP)

Evaluation of Knowledge and Practices About Contraception, Sexuality and Transmission Among Adolescents With Sickle Cell Disease.

Evaluation of knowledge about contraception in sickle cell adolescents.

Study Overview

• Status: Completed
• Conditions: Sickle Cell Disease

Detailed Description

Sickle cell teenagers receive regular hospital medical care.

Adolescence is the time when the pathophysiology of the disease is re-explained and when questions around puberty (possibly delayed), sexuality and contraception are discussed.

Sickle cell disease, like any chronic disease, can have repercussion on the development and behavior of young patients.

Knowledge and understanding of young patients with sickle cell disease around these issues may be insufficient.

• Study Type: Observational
• Enrollment (Actual): 99

Contacts and Locations

Study Locations

• France
  • Creteil
    • Créteil, Creteil, France, 77500
      • Centre Hospitalier Intercommunal de Créteil

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 19 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

The teenagers from 14 to 19 years old followed in the STYLE for a sickle cell disease.

Description

Inclusion Criteria:

• Patients with sickle cell disease followed at the CHIC
• Aged 14 to 19
• Both sexes

Exclusion Criteria:

• Neurological disorders that can impede understanding of the questionnaire.
• Refusal to participate.
• Not affiliated to social security.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Score value of the questionnaire on general knowledge on contraception	questionnaire on general knowledge on contraception rated by 4 questions	at inclusion

Secondary Outcome Measures

Outcome Measure	Time Frame
Score value of the questionnaire on specific knowledge on the transmission of the disease	at inclusion
Score value of the questionnaire on the transmission of the disease knowledge	at inclusion
Score value of the questionnaire on specific knowledge about the impact of sickle cell disease on the course of puberty	at inclusion
Score value of the questionnaire onspecific knowledge about the impact of sickle cell disease on the course of sexuality	at inclusion
age of the patient with sickle cell disease	at inclusion
gender of the patient with sickle cell disease	at inclusion
number of hospitalizations of the patient with sickle cell disease	at inclusion

Collaborators and Investigators

• Sponsor: Adele CARLIER-GONOD

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2017
• Primary Completion (Actual): January 31, 2018
• Study Completion (Actual): January 31, 2018

Study Registration Dates

• First Submitted: July 27, 2017
• First Submitted That Met QC Criteria: July 27, 2017
• First Posted (Actual): August 1, 2017

Study Record Updates

• Last Update Posted (Actual): February 6, 2019
• Last Update Submitted That Met QC Criteria: February 5, 2019
• Last Verified: February 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Hematologic Diseases; Genetic Diseases, Inborn; Anemia; Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Hemoglobinopathies; Anemia, Sickle Cell
• Other Study ID Numbers: SEXODREP

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No